Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001603018-15-000001
Filing Date
2015-09-28
Accepted
2015-09-28 17:06:01
Documents
1
Effectiveness Date
2015-09-28
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11412
  Complete submission text file 0001603018-15-000001.txt   12514
Mailing Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043 650.944.7000
Alexza Pharmaceuticals Inc. (Filer) CIK: 0001344413 (see all company filings)

EIN.: 770567768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-248343 | Film No.: 151128080
SIC: 2834 Pharmaceutical Preparations